Steinmüller T, Klupp J, Rayes N, Ulrich F, Jonas S, Gräf K J, Neuhaus P
Department of Surgery, Virchow-Clinic, Humboldt University, Berlin, Germany.
Eur J Surg. 2000 Jan;166(1):29-33. doi: 10.1080/110241500750009663.
To study the prognostic factors in patients with differentiated thyroid carcinoma.
Retrospective analysis.
University hospital, Germany.
139 consecutive patients who underwent surgery for follicular (n = 42) and papillary thyroid carcinoma (n = 97).
Survival rate, type of operation (systematic lymphadenectomy or no lymphadenectomy).
Median observation time was 72 months (range 1-203). The 5 and 10 year survival rates in patients with papillary carcinoma were 92% and 89% respectively, and in those with follicular carcinoma 88% and 80%, respectively. Prognostic factors for papillary carcinoma were distant metastases, age, and extrathyroidal growth, and for follicular carcinoma they were distant metastases, extrathyroidal extension, and multifocal growth. The Union International contre le Cancer and European Organisation for Research and Treatment of Cancer scores and the age, grade, extent and size score were all highly significant. The extent of lymphadenectomy, primary or secondary thyroidectomy, and partial or total thyroidectomy did not influence survival.
Staging and score systems may be helpful in calculating prognosis in differentiated thyroid carcinoma, but the benefit of systematic lymphadenectomy remains controversial.
研究分化型甲状腺癌患者的预后因素。
回顾性分析。
德国大学医院。
139例连续接受手术治疗的滤泡状甲状腺癌(n = 42)和乳头状甲状腺癌(n = 97)患者。
生存率、手术类型(系统性淋巴结清扫术或未行淋巴结清扫术)。
中位观察时间为72个月(范围1 - 203个月)。乳头状癌患者的5年和10年生存率分别为92%和89%,滤泡状癌患者分别为88%和80%。乳头状癌的预后因素为远处转移、年龄和甲状腺外生长,滤泡状癌的预后因素为远处转移、甲状腺外浸润和多灶性生长。国际抗癌联盟和欧洲癌症研究与治疗组织评分以及年龄、分级、范围和大小评分均具有高度显著性意义。淋巴结清扫范围、初次或二次甲状腺切除术以及部分或全甲状腺切除术均不影响生存率。
分期和评分系统可能有助于计算分化型甲状腺癌的预后,但系统性淋巴结清扫术的益处仍存在争议。